4.87 USD
↗ 0.16 (3.29%)AT CLOSE (11:59 AM EDT)
Atea Pharmaceuticals, Inc. Common Stock
AVIRNASDAQ • USD
4.82
↘ 0.05 (1.03%)
POST MARKET (AS OF 06:01 PM EDT)
Post Market
AS OF 06:01 PM EDT
4.82
↘ 0.05 (1.03%)
Market: OPEN
Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades at $4.86 per share. AVIR shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, AVIR appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 17, 2026.
Open?$4.65
High?$4.90
Low?$4.64
Prev. Close?$4.72
Volume?225.6K
Avg. Volume?336.6K
VWAP?$4.80
Rel. Volume?0.67x
Bid / Ask
Bid?$4.15 × 100
Ask?$5.70 × 100
Spread?$1.55
Midpoint?$4.93
Valuation & Ratios
Market Cap?377.7M
Shares Out?80.0M
Float?60.5M
Float %?75.5%
P/E Ratio?N/A
P/B Ratio?1.62
EPS?-$2.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Employees
55
Market Cap
377.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-10-30
Address
225 FRANKLIN STREET
BOSTON, MA 02110
Phone: (857) 284-8891
BOSTON, MA 02110
Phone: (857) 284-8891
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?54
Momentum?23
Short Sent.?48
Piotroski F-Score?0/9Weak
Altman Z-Score?2.50Grey
Confidence?55%Low
Short InterestVery High
Short % of Float?11.56%High
Short Interest?7.0M
Days to Cover?16.0
Free Float60.5M
Avg Daily Volume436.0K
Settlement Date2026-06-30
Financial Health
Current Ratio?7.89Strong
Quick Ratio?7.89Strong
Cash Ratio?2.38Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.62CHEAP▾
Peers100
S&P84
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-72.5%WEAK▾
S&P3
ROA?-63.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$298.4M
Fundamentals ratios updated end of day